On April 12, 2000, photodynamic therapy (PDT) with verteporfin (Visudyne®) is approved by the FDA for the treatment of neovascular AMD. Developed in the 1990s by Joan W. Miller, MDand Evan...
Frederick H. Verhoeff, MD, Harvard Medical School (HMS) Professor of Ophthalmology and Mass. Eye and Ear's first full-time researcher and pathologist, establishes the first endowed...
Henry Willard Williams, AM, MD, delivers the first course of clinical ophthalmology lectures at Harvard Medical School—the first course of its kind ever given in an American medical school...
